|
|
Volumn 8, Issue 7, 2005, Pages 837-
|
|
Multiple sclerosis woes
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA4 INTEGRIN;
NATALIZUMAB;
VASCULAR CELL ADHESION MOLECULE 1;
VERY LATE ACTIVATION ANTIGEN 4;
MONOCLONAL ANTIBODY;
CLINICAL FEATURE;
CLINICAL TRIAL;
DISABILITY;
DISEASE COURSE;
DISEASE PREDISPOSITION;
DISEASE SEVERITY;
DRUG APPROVAL;
DRUG MECHANISM;
EDITORIAL;
FOOD AND DRUG ADMINISTRATION;
GENE REARRANGEMENT;
HUMAN;
IMMUNOMODULATION;
JC VIRUS;
MULTIPLE SCLEROSIS;
MYELIN SHEATH;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PRIORITY JOURNAL;
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;
T LYMPHOCYTE;
VIRUS GENE;
VIRUS LOAD;
VIRUS REACTIVATION;
VIRUS VIRULENCE;
CHEMICALLY INDUCED DISORDER;
LEUKOENCEPHALOPATHY;
ANTIBODIES, MONOCLONAL;
DRUG APPROVAL;
HUMANS;
LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL;
MULTIPLE SCLEROSIS;
|
|
EID: 33645005385
PISSN: 10976256
EISSN: None
Source Type: Journal
DOI: 10.1038/nn0705-837 Document Type: Editorial |
|
Times cited : (3)
|
|
References (4)
|
